Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Johnson & Johnson

Johnson & Johnson
Regional

Johnson & Johnson Reports Long-Term Data on Myasthenia Drug

April 30, 2026April 28, 2026 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) recently reported new Phase 3 data showing sustained symptom improvement and reduced antibody levels in patients with generalized myasthenia gravis treated with …

Johnson & Johnson Reports Long-Term Data on Myasthenia Drug Read More

Johnson & Johnson
Regional

Johnson & Johnson Reports Psoriasis Drug Results From Phase 3 Studies

April 6, 2026April 6, 2026 - by Timothy Alexander

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced recently that its oral psoriasis treatment ICOTYDE (icotrokinra) achieved sustained skin clearance rates through 52 weeks in Phase 3 clinical …

Johnson & Johnson Reports Psoriasis Drug Results From Phase 3 Studies Read More
Johnson & Johnson
Regional

FDA Approves Johnson & Johnson Psoriasis Drug ICOTYDE

March 29, 2026March 28, 2026 - by Timothy Alexander

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) said the U.S. Food and Drug Administration has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and …

FDA Approves Johnson & Johnson Psoriasis Drug ICOTYDE Read More

Johnson & Johnson
Regional

FDA Approves TECVAYLI and DARZALEX FASPRO Combo for Multiple Myeloma

March 13, 2026March 12, 2026 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved TECVAYLI (teclistamab-cqyv) in combination with DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for adults …

FDA Approves TECVAYLI and DARZALEX FASPRO Combo for Multiple Myeloma Read More
Johnson & Johnson
Regional

Johnson & Johnson Submits FDA Application for IMAAVY in wAIHA

March 6, 2026March 5, 2026 - by Timothy Alexander

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) said it has submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration seeking approval of IMAAVY (nipocalimab-aahu) …

Johnson & Johnson Submits FDA Application for IMAAVY in wAIHA Read More

Johnson & Johnson
Regional

Johnson & Johnson Receives FDA Approval for Monthly RYBREVANT FASPRO Dosing

February 26, 2026February 25, 2026 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved a new monthly dosing schedule for RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), to …

Johnson & Johnson Receives FDA Approval for Monthly RYBREVANT FASPRO Dosing Read More
Court News
Pennsylvania

Philadelphia Jury Awards $250,000 in J&J Talc Cancer Trial

February 23, 2026February 22, 2026 - by Timothy Alexander

PHILADELPHIA, PA — A jury in the Philadelphia Court of Common Pleas awarded $250,000 against Johnson & Johnson (NYSE: JNJ), finding the company’s talc-based baby powder products contributed to the …

Philadelphia Jury Awards $250,000 in J&J Talc Cancer Trial Read More

Governor Josh Shapiro
Pennsylvania

Johnson & Johnson to Invest $1 Billion in Montgomery County Cancer Drug Facility

February 18, 2026February 18, 2026 - by Maryann Pugh

What This Means for You More than 500 new jobs are expected in Montgomery County over the next 12 years. The state will provide up to $41.5 million in financial …

Johnson & Johnson to Invest $1 Billion in Montgomery County Cancer Drug Facility Read More
Johnson & Johnson
Regional

Real-World Study Finds ERLEADA Cuts Death Risk in Advanced Prostate Cancer

February 9, 2026February 9, 2026 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) reported new real-world evidence showing that patients with metastatic castration-sensitive prostate cancer who began treatment with ERLEADA without chemotherapy experienced a sharply …

Real-World Study Finds ERLEADA Cuts Death Risk in Advanced Prostate Cancer Read More
Johnson & Johnson
Regional

FDA Clears Johnson & Johnson Myeloma Combo, Expanding Frontline Care

February 4, 2026February 3, 2026 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) said the U.S. Food and Drug Administration has approved a new frontline treatment option for adults newly diagnosed with multiple myeloma who …

FDA Clears Johnson & Johnson Myeloma Combo, Expanding Frontline Care Read More

Posts pagination

Previous 1 2 3 4 Next

Trending News

  • Lancaster Woman Accused of Trying to Set Home on Fire

  • Parkesburg Woman Arrested on Strangulation Charges

  • Tredyffrin/Easttown Plan Would Shift Elementary Boundaries

  • What Went Wrong at 7 Chester County Restaurants?

  • Camp Saginaw Withdraws New London Township Cell Tower Plan

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Tiffany Michelle Seda

Lancaster Woman Accused of Trying to Set Home on Fire

November 21, 2026November 20, 2026

Police news

Parkesburg Woman Arrested on Strangulation Charges

November 21, 2026November 20, 2026

Court News

Coatesville Woman Pleads Guilty to Voting Illegally Twice

November 20, 2026November 19, 2026

Copyright © 2026 MyChesCo.